AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA)

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2010–2014

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	4	1
2010	—	6	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
SIGNAL GROUP CONSULTING, LLC	—	22

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	20
SENATE	20
Treasury, Dept of	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Insurance	Insurance	22
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	22
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	22
Health Issues	Health Issues	6
Economics/Economic Development	Economics/Economic Development	1

Bills Explicitly Cited (8)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 501111th Congress

Fair Prescription Drug Competition Act

2010 · first_quarter · Firm: SIGNAL GROUP CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Fraternal's 501(c)(8) tax exempt status.

Client expense: — · Firm income: —

Matched citations: s 501

S. 501111th Congress

Fair Prescription Drug Competition Act

2010 · first_quarter · Firm: SIGNAL GROUP CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Fraternal's 501(c)(8) tax exempt status.

Client expense: — · Firm income: —

Matched citations: s 501

S. 501111th Congress

Fair Prescription Drug Competition Act

2010 · first_quarter · Firm: SIGNAL GROUP CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Fraternal's 501(c)(8) tax exempt status.

Client expense: — · Firm income: —

Matched citations: s 501

S. 501111th Congress

Fair Prescription Drug Competition Act

2010 · first_quarter · Firm: SIGNAL GROUP CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Fraternal's 501(c)(8) tax exempt status.

Client expense: — · Firm income: —

Matched citations: s 501

Show 4 more cited filings

S. 501111th Congress

Fair Prescription Drug Competition Act

2010 · first_quarter · Firm: SIGNAL GROUP CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Fraternal's 501(c)(8) tax exempt status.

Client expense: — · Firm income: —

Matched citations: s 501

S. 501111th Congress

Fair Prescription Drug Competition Act

2010 · first_quarter · Firm: SIGNAL GROUP CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Fraternal's 501(c)(8) tax exempt status.

Client expense: — · Firm income: —

Matched citations: s 501

S. 501111th Congress

Fair Prescription Drug Competition Act

2010 · first_quarter · Firm: SIGNAL GROUP CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Fraternal's 501(c)(8) tax exempt status.

Client expense: — · Firm income: —

Matched citations: s 501

S. 501111th Congress

Fair Prescription Drug Competition Act

2010 · first_quarter · Firm: SIGNAL GROUP CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Fraternal's 501(c)(8) tax exempt status.

Client expense: — · Firm income: —

Matched citations: s 501

Source: Senate LDA

AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) — Lobbying Disclosure | Poliscope